학술논문

Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)
Document Type
Article
Source
In: BMJ Open. (BMJ Open, 15 March 2024, 14(3))
Subject
Language
English
ISSN
20446055